SRB Corp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1,418
| Closed | -$404K | – | 98 |
|
2023
Q2 | $404K | Buy |
+1,418
| New | +$404K | 0.02% | 94 |
|
2023
Q1 | – | Sell |
-1,457
| Closed | -$404K | – | 116 |
|
2022
Q4 | $404K | Buy |
+1,457
| New | +$404K | 0.03% | 92 |
|
2022
Q3 | – | Sell |
-7,641
| Closed | -$1.56M | – | 106 |
|
2022
Q2 | $1.56M | Buy |
7,641
+2,329
| +44% | +$475K | 0.1% | 22 |
|
2022
Q1 | $1.12M | Hold |
5,312
| – | – | 0.06% | 100 |
|
2021
Q4 | $1.27M | Buy |
5,312
+453
| +9% | +$109K | 0.07% | 114 |
|
2021
Q3 | $1.38M | Buy |
+4,859
| New | +$1.38M | 0.08% | 96 |
|
2020
Q4 | – | Sell |
-2,020
| Closed | -$573K | – | 166 |
|
2020
Q3 | $573K | Buy |
2,020
+433
| +27% | +$123K | 0.05% | 73 |
|
2020
Q2 | $424K | Hold |
1,587
| – | – | 0.03% | 142 |
|
2020
Q1 | $502K | Buy |
+1,587
| New | +$502K | 0.05% | 18 |
|
2019
Q4 | – | Sell |
-1,959
| Closed | -$457K | – | 149 |
|
2019
Q3 | $457K | Sell |
1,959
-148
| -7% | -$34.5K | 0.04% | 131 |
|
2019
Q2 | $492K | Sell |
2,107
-109
| -5% | -$25.5K | 0.05% | 116 |
|
2019
Q1 | $524K | Buy |
2,216
+436
| +24% | +$103K | 0.05% | 119 |
|
2018
Q4 | $536K | Buy |
+1,780
| New | +$536K | 0.06% | 41 |
|
2018
Q3 | – | Sell |
-1,697
| Closed | -$492K | – | 168 |
|
2018
Q2 | $492K | Buy |
1,697
+984
| +138% | +$285K | 0.05% | 104 |
|
2018
Q1 | $195K | Buy |
713
+91
| +15% | +$24.9K | 0.02% | 127 |
|
2017
Q4 | $198K | Hold |
622
| – | – | 0.03% | 114 |
|
2017
Q3 | $195K | Sell |
622
-105
| -14% | -$32.9K | 0.03% | 39 |
|
2017
Q2 | $197K | Buy |
727
+101
| +16% | +$27.4K | 0.03% | 31 |
|
2017
Q1 | $171K | Buy |
626
+88
| +16% | +$24K | 0.02% | 137 |
|
2016
Q4 | $153K | Buy |
538
+36
| +7% | +$10.2K | 0.02% | 162 |
|
2016
Q3 | $157K | Hold |
502
| – | – | 0.02% | 90 |
|
2016
Q2 | $121K | Buy |
+502
| New | +$121K | 0.02% | 177 |
|